Department of Pediatrics, School of Medicine, University of California, San Francisco, San Francisco, CA.
Division of Pulmonology, Department of Pediatrics, School of Medicine, University of California, San Francisco, San Francisco, CA.
Pediatr Crit Care Med. 2020 Oct;21(10):e879-e887. doi: 10.1097/PCC.0000000000002358.
Data on outcomes of children with cystic fibrosis admitted to PICUs are limited and outdated. Prior studies cite PICU mortality rates ranging from 37.5% to 100%. Given the advances made in cystic fibrosis care, we expect outcomes for these patients to have changed significantly since last studied. We provide an updated report on PICU mortality and the factors associated with death among critically ill children with cystic fibrosis.
Retrospective multicenter cohort analysis utilizing data from the Virtual Pediatric Systems database.
Data were collected from 135 PICUs from January 1, 2009, to June 20, 2018.
One-thousand six-hundred thirty-three children with cystic fibrosis accounting for 2,893 PICU admissions were studied.
None.
The primary outcome was mortality during PICU admission. Predictors included demographics, anthropometrics, diagnoses, clinical characteristics, and critical care interventions. Odds ratios of mortality were calculated in univariate and multivariable analyses to assess differences in mortality associated with predictor variables. Generalized estimating equation models were used to account for multiple admissions per patient. The overall PICU mortality rate was 6.6%. Factors associated with increased odds of mortality included hemoptysis/pulmonary hemorrhage, pneumothorax, gastrointestinal bleeding, bacterial/fungal infections, lower body mass index/malnutrition, and need for noninvasive or invasive respiratory support. Intubation/mechanical ventilation occurred in 26.4% of the 2,893 admissions and was associated with a 19.1% mortality rate. Of the nonsurvivors, 20.7% died without receiving mechanical ventilation.
The mortality rate during PICU admissions for patients with cystic fibrosis is lower than has been reported in prior studies, both in the overall cohort and in the subset requiring invasive mechanical ventilation. These data provide updated insight into the prognosis for cystic fibrosis patients requiring critical care.
小儿危重症监护病房(PICU)收治的囊性纤维化患儿的结局数据有限且已过时。既往研究报道的 PICU 死亡率范围为 37.5%至 100%。鉴于囊性纤维化治疗方面的进展,我们预计自上次研究以来,这些患者的结局已发生显著变化。我们提供了一份关于 PICU 死亡率和与危重症囊性纤维化患儿死亡相关因素的最新报告。
利用虚拟儿科系统数据库中的数据进行回顾性多中心队列分析。
数据来自 2009 年 1 月 1 日至 2018 年 6 月 20 日期间的 135 个 PICU。
研究纳入了 1633 例囊性纤维化患儿,共 2893 例 PICU 入院。
无。
主要结局为 PICU 住院期间的死亡率。预测因素包括人口统计学、人体测量学、诊断、临床特征和重症监护干预措施。采用单变量和多变量分析计算死亡率的比值比,以评估与预测变量相关的死亡率差异。广义估计方程模型用于解释每位患者的多次入院。总体 PICU 死亡率为 6.6%。与死亡风险增加相关的因素包括咯血/肺出血、气胸、胃肠道出血、细菌/真菌感染、较低的体重指数/营养不良以及需要无创或有创呼吸支持。2893 例入院中有 26.4%需要插管/机械通气,其死亡率为 19.1%。在死亡的患者中,20.7%的患者在未接受机械通气的情况下死亡。
囊性纤维化患儿 PICU 住院期间的死亡率低于既往研究报道,无论是在总体队列中还是在需要有创机械通气的亚组中。这些数据提供了有关需要重症监护的囊性纤维化患者预后的最新见解。